Skip to Main Content

Paper Details

Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy.
Haematologica
3
2022
Decitabine, acute myeloid leukemia
Author NameAffiliation
Francesca FerraroWashington University School of Medicine
Christopher A MillerWashington University School of Medicine
Peter WesterveltWashington University School of Medicine
John F DiPersioWashington University School of Medicine
Lukas D WartmanWashington University School of Medicine
Daniel C LinkWashington University School of Medicine
Timothy J LeyWashington University School of Medicine
  • 1 - 7

Datasets

Release 1.2